Cite
HARVARD Citation
Coulson, A. et al. (2022). Frailty-adjusted therapy in Transplant Non-Eligible patients with newly diagnosed Multiple Myeloma (FiTNEss (UK-MRA Myeloma XIV Trial)): a study protocol for a randomised phase III trial. BMJ open. 12 (6), p. . [Online].